PROTEOMIC ANALYSIS OF CARFILZOMIB (CFZ) RELATED HEART FAILURE IN MULTIPLE MYELOMA (MM) PATIENTS FROM PROSPECTIVE STUDY OF CARDIAC EVENTS DURING PROTEASOME INHIBITOR THERAPY (PROTECT) STUDY

被引：0
|
作者：
Shabnaz, S. [1 ]
Williams, R. [1 ]
Rubinstein, S. [2 ]
Fradley, M. [3 ]
Baz, R. [4 ]
Pepine, C. [1 ]
Lenihan, D. [5 ]
Cornell, R. [6 ]
Gong, Y. [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Univ Penn, Philadelphia, PA USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[5] St Francis Med Ctr, Cape Girardeau, MO USA
[6] AbbVie, Chicago, IL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-052
引用
收藏
页码：S61 / S61
页数：1
相关论文
共 50 条
  • [41] How many patients admitted for heart failure are eligible for cardiac resynchronization therapy?: Analysis of the Andalusian Heart Failure Registry (RAIC) Study
    Garcia-Pinilla, Jose M.
    Jimenez-Navarro, Manuel F.
    Anguita-Sanchez, Manuel
    Martinez-Martinez, Angel
    Torres-Calvo, Francisco
    REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (01): : 38 - 44
  • [42] Superior Efficacy of Carfilzomib and Dexamethasone (Kd56) Vs Bortezomib and Dexamethasone (Vd) in Multiple Myeloma (MM) Patients with Moderate or Serious Renal Failure: A Subgroup Analysis of the Phase 3 Endeavor Study
    Dimopoulos, Meletios A.
    Siegel, David
    White, Darrell J.
    Boccia, Ralph V.
    Yang, Zhao
    Kimball, Amy S.
    Iskander, Karim Saad
    Mezzi, Khalid
    Ludwig, Heinz
    Niesvizky, Ruben
    BLOOD, 2017, 130
  • [43] A Phase 1/2 Study of Weekly MLN9708, an Investigational Oral Proteasome Inhibitor, in Combination with Lenalidomide and Dexamethasone in Patients with Previously Untreated Multiple Myeloma (MM)
    Kumar, Shaji K.
    Berdeja, Jesus G.
    Niesvizky, Ruben
    Lonial, Sagar
    Hamadani, Mehdi
    Stewart, A. Keith
    Roy, Vivek
    Hari, Parameswaran
    Vescio, Robert
    Berg, Deborah
    Lin, Jianchang
    Di Bacco, Alessandra
    Gupta, Neeraj
    Hui, Ai-Min
    Richardson, Paul G.
    BLOOD, 2012, 120 (21)
  • [44] Phase I study of twice-weekly dosing of the investigational oral proteasome inhibitor MLN9708 in patients (pts) with relapsed and/or refractory multiple myeloma (MM).
    Lonial, Sagar
    Baz, Rachid C.
    Wang, Michael
    Talpaz, Moshe
    Liu, Guohui
    Berg, Deborah
    Gupta, Neeraj
    Di Bacco, Alessandra
    Hui, Ai-Min
    Richardson, Paul Gerard Guy
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] Phase 1/2 Study of Oral MLN9708, A Novel, Investigational Proteasome Inhibitor, in Combination with Lenalidomide and Dexamethasone in Patients with Previously Untreated Multiple Myeloma (MM)
    Berdeja, Jesus G.
    Richardson, Paul G.
    Lonial, Sagar
    Niesvizky, Ruben
    Hui, Ai-Min
    Berg, Deborah
    Gupta, Neeraj
    Liu, Guohui
    Di Bacco, Alessandra
    Kumar, Shaji
    BLOOD, 2011, 118 (21) : 223 - 223
  • [46] A phase II multicenter randomized study of the proteasome inhibitor bortezomib (VELCADE™, formerly PS-341) in multiple myeloma (MM) patients (pts) relapsed after front-line therapy.
    Jagannath, S
    Barlogie, B
    Berenson, J
    Siegel, D
    Irwin, D
    Richardson, PG
    Alexanian, R
    Limentani, SA
    Alsina, M
    Lee, S
    Esseltine, DL
    Kauffman, M
    Adams, J
    Schenkein, DP
    Anderson, KC
    BLOOD, 2002, 100 (11) : 812A - 812A
  • [47] Do heart failure patients with right bundle branch block benefit from cardiac resynchronization therapy? Analysis of the MIRACLE study
    Aranda, JM
    Curtis, AB
    Conti, JB
    Peterson-Stejskal, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 96A - 96A
  • [48] Impact of Serial Troponin Release on Outcomes in Patients With Acute Heart Failure Analysis From the PROTECT Pilot Study
    O'Connor, Christopher M.
    Fiuzat, Mona
    Lombardi, Carlo
    Fujita, Kenji
    Jia, Gang
    Davison, Beth A.
    Cleland, John
    Bloomfield, Daniel
    Dittrich, Howard C.
    DeLucca, Paul
    Givertz, Michael M.
    Mansoor, George
    Ponikowski, Piotr
    Teerlink, John R.
    Voors, Adriaan A.
    Massie, Barry M.
    Cotter, Gad
    Metra, Marco
    CIRCULATION-HEART FAILURE, 2011, 4 (06) : 724 - 732
  • [49] CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE VS LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND EARLY PROGRESSION DURING PRIOR THERAPY: SECONDARY ANALYSIS FROM THE PHASE 3 STUDY ASPIRE (NCT01080391)
    Rocafiguera Albert, Oriol
    Laura, Rosinol
    Jesus F, San-Miguel
    Heinz, Ludwig
    Meletios A, Dimopoulos
    Tamas, Masszi
    Spic
    Ivan, Ka
    Roman, Hajek
    David S, Siegel
    Georgi G, Mihaylov
    Vesselina, Goranova-Marinova
    Peter, Rajnics
    Aleksandr, Suvorov
    Ruben, Niesvizky
    Andrzej J, Jakubowiak
    Mihaela, Obreja
    Sanjay, Aggarwal
    Philippe, Moreau
    Antonio, Palumbo
    HAEMATOLOGICA, 2016, 101 : 27 - 28
  • [50] Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study
    Motiwala, Shweta R.
    Szymonifka, Jackie
    Belcher, Arianna
    Weiner, Rory B.
    Baggish, Aaron L.
    Sluss, Patrick
    Gaggin, Hanna K.
    Bhardwaj, Anju
    Januzzi, James L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (10) : 1157 - 1163
12345